These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2517312)

  • 21. Lithium carbonate in the preoperative preparation of Graves' disease.
    Tsunoda T; Mochinaga N; Eto T; Yamaguchi M; Tsuchiya R; Izumi M
    Jpn J Surg; 1991 May; 21(3):292-6. PubMed ID: 1713279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy.
    Antonelli A; Fallahi P; Rotondi M; Ferrari SM; Serio M; Miccoli P
    Br J Surg; 2006 Oct; 93(10):1226-31. PubMed ID: 16838393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Quality of life of patients before and after surgical treatment of diffuse toxic goiter].
    Il'icheva EA; Zudaev VP; Roĭ TA; Makhutov VN; Tarnueva IF; Moshkova ES
    Vestn Khir Im I I Grek; 2011; 170(4):58-63. PubMed ID: 22191260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The method of toxic goiter surgical treatment].
    Zhuraev ShSh; Baĭmakhanov BB; Kyzhyrov ZhN
    Khirurgiia (Mosk); 2009; (5):68-71. PubMed ID: 19491772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Changes in the hormone profile, central hemodynamics and tissue blood flow in patients with thyrotoxic goiter during treatment with lithium carbonate].
    Petrov IM
    Med Radiol (Mosk); 1986 Apr; 31(4):13-5. PubMed ID: 3083189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of methimazole on warfarin anticoagulation in a case of Graves' disease.
    Akin F; Yaylali GF; Bastemir M; Yapar B
    Blood Coagul Fibrinolysis; 2008 Jan; 19(1):89-91. PubMed ID: 18180622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [On the residual thyroid tissue after thyroidectomy for diffuse goiter with thyrotoxicosis].
    Angelescu E; Stoenescu D; Damian A; Taşcă C
    Stud Cercet Endocrinol; 1973; 24(6):465-71. PubMed ID: 4129363
    [No Abstract]   [Full Text] [Related]  

  • 28. Benefit of short-term iodide supplementation to antithyroid drug treatment of thyrotoxicosis due to Graves' disease.
    Takata K; Amino N; Kubota S; Sasaki I; Nishihara E; Kudo T; Ito M; Fukata S; Miyauchi A
    Clin Endocrinol (Oxf); 2010 Jun; 72(6):845-50. PubMed ID: 19912243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intraoperative hypertension during thyroidectomy for Graves' disease.
    Sharma AK; Mishra SK; Mithal A
    J Assoc Physicians India; 1995 May; 43(5):334-5. PubMed ID: 9081963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Surgical treatment of recurrent goiter].
    Sedov VM; Sedletskiĭ IuI; Belianina EO
    Vestn Khir Im I I Grek; 1999; 158(5):53-6. PubMed ID: 10645583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Thyroid hormones, thyrotropin, cortisol and corticotropin in postoperative recurrence of diffuse toxic goiter].
    Karachentsev IuI; Grinchenko TS; Alesina MIu
    Sov Med; 1988; (8):5-7. PubMed ID: 2849214
    [No Abstract]   [Full Text] [Related]  

  • 32. Lithium carbonate in the treatment of thyrotoxicosis. A controlled trial.
    Kristensen O; Andersen HH; Pallisgaard G
    Lancet; 1976 Mar; 1(7960):603-5. PubMed ID: 55890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The surgical treatment of toxic goiter and the prevention of its complications in light of current concepts of the pathogenesis of the diseases].
    Cheren'ko MP; Ignatovskiĭ IuV; Cheren'ko SM; Tokman PA
    Klin Khir (1962); 1991; (12):1-4. PubMed ID: 1798241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Dynamics of interleukin 2 production in patients with diffuse toxic goiter under the influence of treatment].
    Shatsova EN; Malaitsev VV; Bogdanova IM
    Probl Endokrinol (Mosk); 1988; 34(6):24-6. PubMed ID: 2976937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Lithium carbonate in the treatment of diffuse toxic goiter].
    Leshchinskiĭ LA; Trusov VV; Pimenov LT
    Ter Arkh; 1982; 54(2):113-8. PubMed ID: 6803379
    [No Abstract]   [Full Text] [Related]  

  • 36. [Adrenal hormones in patients with diffuse toxic goiter before and after surgery].
    Titov VN; Riekstinia GIa
    Vestn Khir Im I I Grek; 1970 Dec; 105(12):18-21. PubMed ID: 5537959
    [No Abstract]   [Full Text] [Related]  

  • 37. [Postoperative course and tactics of aftercare in hyperthyroidism].
    de Heer K; Schnippenkoetter I; Kortmann KB; Beeger R
    Chirurg; 1984 Mar; 55(3):171-3. PubMed ID: 6546914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Spontaneous hypothyroidism in 4 patients with Graves-Basedow disease].
    González-González A; Recio Cordova JM; Aznar Ondoño I; Del Monte Jarabo Bueno M
    Endocrinol Nutr; 2009 May; 56(5):273-6. PubMed ID: 19627750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Ways to decrease postoperative hypothyroidism in patients with diffuse toxic goiter].
    Kirillov IuB; Aristarkhov VG; Panteleev IV; Potapov AA; Korviakov AP; Poliakov AV
    Vestn Khir Im I I Grek; 1994; 152(3-4):66-8. PubMed ID: 7709540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Lithium acetate, a useful and well tolerated thyrostatic for selected cases of hyperthyroidism].
    Eigenmann F; Bürgi H
    Schweiz Med Wochenschr; 1978 Nov; 108(47):1850-3. PubMed ID: 581407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.